RxDoctor Payments Data

Nicholas Smith

Physician Assistant · Madison, WVNPI 1841476231

Payments from drug & device makers

$2,790in general payments, 2019–2025

Across 154 payments — averaging $18.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$649
  • AbbVie$500
  • Pfizer$346
  • Exact Sciences$200
  • Boehringer Ingelheim$133
  • AstraZeneca$132
  • plus $829 from 17 others

What the payments were for

  • Food & beverage$2,790100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,790 in reported general payments places this provider in the 90th percentile of 833 physician assistant providers in West Virginia.

See all physician assistant providers in West Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
ZenpepLipase/Protease/Amylase26$64,995
OzempicSemaglutide31$47,024
LinzessLinaclotide39$25,045
EliquisApixaban31$24,328
TrulicityDulaglutide19$23,528
FarxigaDapagliflozin Propanediol26$23,016
JardianceEmpagliflozin19$18,963
VascepaIcosapent Ethyl31$16,608
EntrestoSacubitril/Valsartan11$13,936
CreonLipase/Protease/Amylase13$10,714
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$9,136
Tresiba Flextouch U-100Insulin Degludec12$7,916
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/713$7,773
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog15$7,292
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$6,832

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$649$47,02431 claims
AbbVieLinzess, Creon, Synthroid$500$37,91686 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$132$36,90352 claims
Boehringer IngelheimJardiance, Combivent Respimat$133$24,48631 claims
PfizerEliquis$346$24,32831 claims
Lilly USA, LLCTrulicity$117$23,52819 claims
NovartisEntresto$98$13,93611 claims
GSKTrelegy Ellipta$45$6,83211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 833 physician assistant providers in West Virginia.

Other physician assistant in Madison

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →